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Deubiquitinating enzymes (DUBs) constitute a large
family of cysteine proteases that have a broad
impact on numerous biological and pathological
processes, including the regulation of genomic
stability. DUBs are often assembled onto multipro-
tein complexes to assist in their localization and
substrate selection, yet it remains unclear how the
enzymatic activity of DUBs is modulated by intra-
cellular signals. Herein, we show that bursts of
reactive oxygen species (ROS) reversibly inactivate
DUBs through the oxidation of the catalytic cysteine
residue. Importantly, USP1, a key regulator of ge-
nomic stability, is reversibly inactivated upon oxida-
tive stress. This, in part, explains the rapid nature of
PCNA monoubiquitination-dependent DNA damage
tolerance in response to oxidative DNA damage
in replicating cells. We propose that DUBs of the
cysteine protease family act as ROS sensors in
human cells and that ROS-mediated DUB inacti-
vation is a critical mechanism for fine-tuning stress-
activated signaling pathways.
INTRODUCTION
Deubiquitinating enzymes (DUBs) are proteases that cleave
ubiquitin or ubiquitin-like proteins from proproteins or conju-
gates with target proteins (Reyes-Turcu et al., 2009). In doing
so, DUBs maintain balance of ubiquitination dynamics, playing
an editing role analogous to that of the phosphatases in
kinase/phosphatase regulatory pathways. Deubiquitination is
a highly regulated process that has been implicated in numerous
cellular functions, including cell-cycle regulation (Song and
Rape, 2008), proteasome- and lysosome-dependent protein
degradation (Guterman and Glickman, 2004), gene expression,
kinase activation (Grabbe et al., 2011; Skaug et al., 2009), micro-
bial pathogenesis (Lindner, 2007; Rytko¨nen and Holden, 2007),
and DNA repair (Huang and D’Andrea, 2006; Messick and
Greenberg, 2009). Mutations in several DUBs have been linked
to diseases ranging from cancer to neurological disorders (FraileCell Reet al., 2012; Sacco et al., 2010; Singhal et al., 2008; Todi and
Paulson, 2011). Although a few substrates have been identified
for a handful of DUBs, the substrates and physiological roles
of most DUBs are poorly defined. In addition, the regulation of
DUB activity has only emerged recently. Several studies have
shown that DUB activity is dependent on the presence of
substrate or a scaffolding protein, which enables conformational
changes toward catalytic competency (Cohn et al., 2007; Das
et al., 2006; Hu et al., 2002; Yao et al., 2006). DUBs are also
posttranslationally modified by phosphorylation, ubiquitination,
or sumoylation, which alters activity, localization, or half-life
(Reyes-Turcu et al., 2009). Thus, similar to other proteases,
DUB activity is carefully controlled to prevent spurious cleavage
of substrates; however, the participation of endogenous small
molecules in modulating DUB activity has been unexplored.
There are nearly 100 putative ubiquitin-specific DUBs en-
coded by the human genome, and they belong to five different
families (Komander, 2010; Reyes-Turcu et al., 2009). Four fami-
lies belong to Clan A of cysteine proteases: ubiquitin C-terminal
hydrolase (UCH), ubiquitin-specific protease (USP/UBP),
ovarian tumor domain (OTU), and Josephin domain (MJD)
DUBs (Rawlings et al., 2012). The Cys-dependent deubiquiti-
nases contain a catalytic diad or triad whereby a His residue
lowers the pKa of a nucleophilic Cys residue, priming it for
attack of the isopeptide linkage of a ubiquitinated substrate.
To complete the triad, an Asp or Asn aligns and polarizes the
His residue. The fifth family of DUBs belongs to the JAB1/
MPN/Mov34 metalloenzyme (JAMM) domain family of zinc-
dependent metalloproteases. This family utilizes invariant His,
Asp/Glu, and Ser residues to coordinate two zinc ions for acti-
vation of a water molecule (Maytal-Kivity et al., 2002; Tran
et al., 2003). Thus, two very different catalytic mechanisms exist
within the five families of DUBs: one involves nucleophilic attack
of the substrate by a Cys thiolate, whereas the other involves
direct attack by a water molecule. Little is known about how
these differences reveal themselves in terms of susceptibility
to cellular signals, including endogenous small molecules.
One such family of endogenous small molecules are reactive
oxygen species (ROS), which are generated during mitochon-
drial oxidative metabolism as well as in cellular response to
xenobiotics, cytokines, bacterial invasion, and replication stress
(Ray et al., 2012). Oxidative stress is an imbalance between
ROS or oxidants and the ability of the cell to mount an effectiveports 2, 1475–1484, December 27, 2012 ª2012 The Authors 1475
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Figure 1. Oxidation of USP1 Is Dependent on Its Catalytic Site Competency
(A) PCNAmonoubiquitination is transiently induced by oxidative stress, whereas checkpoint activation is prolonged. T98G andU2OS cells were treatedwith H2O2
(final concentration 1 mM) for the indicated amount of time. Samples were collected, lysed, and analyzed by western blot with the indicated antibodies.
(legend continued on next page)
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antioxidant response. Although oxidative stress results in
macromolecular damage and is implicated in various disease
states, including atherosclerosis, diabetes (Paravicini and Touyz,
2006), neurodegeneration (Andersen, 2004), aging (Haigis and
Yankner, 2010), and cancer (Trachootham et al., 2009), accumu-
lating evidence indicates that ROS also serve as critical signaling
molecules in cell proliferation and survival. Although there is
a wealth of research demonstrating the general effect of oxida-
tive stress on DNA damage and signaling pathways, less is
known about the signaling targets of ROS. Protein tyrosine phos-
phatases (PTPs) are a family of redox-regulated proteins that
have been studied in recent years (Tonks, 2006). PTPs can be
directly inactivated by ROS through the oxidation of the catalytic
Cys residue (den Hertog et al., 2005; Salmeen andBarford, 2005;
Tonks, 2005). The inactivation of PTPs by ROS is typically
transient and, under physiological conditions, the oxidized Cys
residues are often reduced to the catalytically active thiolate.
Thus, the reversibility of the reaction fine-tunes the signaling
pathways emanating from receptor tyrosine kinases.
In our study, we investigate the susceptibility of DUBs to
redox regulation in vivo. Strikingly, we find that the Cys protease
family of DUBs can be rapidly targeted by oxidative stress. We
show that USP1, a DUB critical for the maintenance of genomic
stability (Jones et al., 2011; Kim et al., 2009), is transiently
oxidized and inactivated in response to oxidative stress in vivo,
suggesting that USP1 is responsible for fine-tuning the prolifer-
ating cell nuclear antigen (PCNA)monoubiquitination-dependent
DNA damage tolerance response to oxidative DNA damage
during S phase. Due to the intractability of USP1 in vitro, we
used the DUB USP7 (HAUSP), an important regulator of the
p53 tumor suppressor and genotoxic pathways (Khoronenkova
and Dianov, 2012; Khoronenkova et al., 2012), to identify the
catalytic Cys residue as the point of oxidative modification,
explaining how DUBs can be mechanistically inactivated by
oxidative stress. Importantly, our in vitro studies show that only(B) Oxidative stress-induced PCNA monoubiquitination is dependent on an inta
pressing HA-PCNA wild-type (WT) or HA-PCNA K164R mutant were left untreate
Samples were collected, lysed, and analyzed by western blot with the indicated
(C) Oxidative stress-induced PCNA monoubiquitination mainly occurs during S p
Cells were then replenished with fresh media and collected at the indicated time
0.5 mM H2O2. Synchronized cells were treated at 0 hr after release from serum d
24 hr of release for early S phase. Samples were collected, lysed, and analyzed b
cross-reactive band when probing with anti-phospho Chk1 antibody (p317).
(D) Depletion of Rad18 results in increased Chk1 activation. U2OS cells were tra
treated with H2O2 (final concentration 0.5 mM) for the indicated amount of time. S
antibodies. Asterisk indicates a nonspecific, cross-reactive band.
(E) The antioxidant activity of Tempol reduces the levels of PCNA monoubiquitin
(0.5 mM) were treated with H2O2 (final concentration 0.3 mM) for the indicated am
the indicated antibodies.
(F) Depletion of USP1 further elevates PCNA monoubiquitination in the presence
siRNA or USP1 siRNA. Cells were then treated with H2O2 (final concentration 0.3
with the indicated antibodies.
(G) Oxidation of USP1 catalytic Cys to the sulfenic acid intermediate can be captu
WT or (DDAA)-Mycmutant alongwith Xpress-UAF1. Cells were then treatedwith H
two separate reactions: labeling with DCP-Bio1 probe or with the UbVME DUB ac
(H) Oxidative stress does not disrupt the binding between Usp1 and UAF1 in ce
Usp1-Myc WT and Xpress-UAF1 and treated with H2O2 (final concentration 1 m
antibody and probed with indicated antibodies.
See also Figure S1.
Cell ReCys-based DUBs, not metalloprotease DUBs, undergo ROS-
mediated catalytic inactivation, even though both families
are susceptible to direct redox control. Thus, our data suggest
that DUBs of the Cys protease family act as ROS sensors in
human cells and that ROS-mediated DUB inactivation is a critical
mechanism for fine-tuning stress-activated signaling pathways.
RESULTS AND DISCUSSION
Rapid and Transient S Phase-Dependent
Monoubiquitination of PCNA Tempers the G2
Checkpoint Activation after Oxidative Stress
Posttranslational modification of PCNA by monoubiquitination
on Lys 164 plays an important role in coordinating DNA damage
tolerance during DNA replication in mammalian cells (Bienko
et al., 2005; Kannouche et al., 2004). The ubiquitin E3 ligase
Rad18 monoubiquitinates PCNA in response to blocks in the
progression of the replication fork caused by DNA lesions
(Hoege et al., 2002; Watanabe et al., 2004). We previously
showed that the DUB USP1 is an important negative regulator
of the DNA damage tolerance pathway via the deubiquitination
of PCNA, which is responsible for preventing the aberrant
recruitment of error-prone translesion synthesis (TLS) DNA
polymerases to the replication fork (Huang et al., 2006; Jones
et al., 2011). Certain DNA-damaging agents, such as UV irradia-
tion, can concomitantly promote the degradation of USP1 to
enhance PCNA monoubiquitination (Cotto-Rios et al., 2011;
Huang et al., 2006; Niimi et al., 2008). A more recent report
showed that cells treated with the oxidizing agent hydrogen
peroxide (H2O2) results in high levels of PCNA monoubiquitina-
tion and, unlike UV irradiation and other DNA-damaging agents,
this is a rapid and reversible response (Zlatanou et al., 2011).
We found similar kinetics of PCNA monoubiquitination after
H2O2 treatment in the U2OS osteosarcoma or T98G glioblas-
toma cell lines (Figure 1A, Figure S1A) and, importantly, thect Lys 164 site but independent of USP1 degradation. U2OS cells stably ex-
d or treated with 50 J/M2 UVC for 3 hr or treated with 1 mM H2O2 for 30 min.
antibodies.
hase. T98G cells were synchronized in G0/G1 by serum deprivation for 72 hr.
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y western blot with the indicated antibodies. Asterisk indicates a nonspecific,
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steady-state levels of USP1 remained unchanged despite the
robust activation of PCNA monoubiquitination 30–60 min post-
treatment (Figure 1A). This is in contrast to UV-mediated DNA
damage whereby USP1 is degraded to enhance PCNA monou-
biquitination, suggesting that alternate mechanisms inhibit
USP1 activity in a time-dependent manner (Figure 1B). Addition-
ally, the activation of PCNA monoubiquitination by oxidative
stress appeared to be most active during S phase and nearly
nonexistent in G0 or G1 phase of the cell cycle (Figure 1C).
Oxidative stress also activated the DNA damage checkpoint
response as shown by the phosphorylation of Ser317 of Chk1
(Figures 1A and 1C). Importantly, depletion of Rad18, which
abolished PCNA monoubiquitination, resulted in increased
Chk1 phosphorylation after oxidative stress (Figure 1D). This is
probably due to the reduced ability of cells to tolerate or bypass
oxidative DNA damage, which will cause more stalling of the
replication fork, Chk1 signaling, and G2 checkpoint activation.
In the absence of checkpoint signaling with caffeine treatment
(Kannouche et al., 2001), PCNA K164R-expressing cells are
marginally sensitive to H2O2 treatment (Figure S1B). Elevated
ROS levels are probably the cause of oxidative DNA damage,
because treatment of cells with a superoxide scavenger, Tem-
pol, reduced the monoubiquitination of PCNA (Figure 1E).
Oxidation of USP1 Is Dependent on Its Catalytic
Competency
To address the role of USP1 in regulating PCNAmonoubiquitina-
tion after oxidative DNA damage, we used siRNAs to deplete
USP1 and found that PCNA monoubiquitination levels were
further increased in response to oxidative stress (Figure 1F).
This provides evidence that USP1 is indeed a critical regulator
of oxidative DNA damage-induced PCNA monoubiquitination.
Next, we tested whether USP1 could be a direct target of oxida-
tive stress, andwhether this could affect its catalytic activity. Cys
oxidation by H2O2 results in the formation of sulfenic (SOH),
sulfinic (SO2H), or sulfonic (SO3H) acid, which represents
the addition of one, two, or three oxygen molecules, respec-
tively. Although sulfenic acid conversion is reversible due to its
propensity to react with other thiol groups or thiol-containingFigure 2. Reversible Inhibition of DUBs by Oxidative Stress
(A) Temporal analysis of ROS levels inside cells after H2O2 treatment. T98G cells w
time (top and bottom left). Cells were trypsinized, collected, and incubated with C
were left untreated or treated with 0.3 mMH2O2 for 30min, 50 J/M
2 UVC for 30min
and incubated with CM-H2DCFDA for FACS analysis. Error bars represent SD of
(B) USP1 and USP7 are reversibly inactivated by oxidative stress and correlate w
untreated or treated with a final concentration of 1 mM H2O2 for the indicated tim
probe and by whole-cell lysis to assess the ubiquitination status of PCNA and p
(C) Ectopically expressedDUBs are similarly affected by oxidative stress as their e
wild-type Flag-USP7 or Flag-USP28 expression constructs. Then cells were left u
Samples were then collected and processed for DUB activity assay as in (B) and
appear are probably different isoforms of USP28 (USP28 antibody).
(D) Tempol can reverse the DUB catalytic inhibition by oxidative stress. U2OS ce
or presence of Tempol. Cells were then trypsinized, collected, and incubated w
processed for DUB activity assay as in (B).
(E) ROS-inactivated USP7 in U2OS cells can be reversed after in vitro DTT treatm
preincubated on ice with 20 mM DTT (or not) prior to the labeling with UbVME a
(F) Recombinant USP7 can be reversibly inhibited by ROS in vitro. His-tagged
K48-linked tetraubiquitin chains in the presence or absence of H2O2 (1 mM) prein
See also Figure S1.
Cell Reproteins to generate a disulfide, the sulfonic and sulfinic acid
forms are typically considered irreversible end products (Clai-
borne et al., 1999). If USP1 is a direct target of oxidative stress,
it is important to determine which oxidation state it exists in.
Recently, the synthesis of several dimedone-based chemose-
lective reagents capable of labeling, enriching, and subsequent
identification of sulfenic acid-modified proteins was reported
(Charles et al., 2007; Poole et al., 2007; Reddie et al., 2008).
Herein, we used a biotin-tagged 1,3-cyclohexadione derivative,
DCP-Bio1 (Figure 1G), to investigate the oxidation status of
USP1 in response to oxidative stress. Because the analysis of
the endogenous USP1 oxidation state was difficult to assess
due to the lowabundance of activeUSP1pool in cells (Figure 2B),
exogenous USP1 was coexpressed in U2OS cells along with its
catalytic cofactor UAF1 to ensure higher levels of active DUB.
Upon H2O2 treatment, we found that exogenously expressed
C-terminally epitope-tagged mouse Usp1 (Usp1-Myc) was
labeled by DCP-Bio1 in cell lysates (Figure 1G), suggesting
that Usp1 was oxidized to the sulfenic acid intermediate in
response to oxidative stress. To determine whether the labeling,
and therefore oxidation, of USP1 was dependent on its catalytic
competency, we tested labeling of USP1 mutated in the active
site His domain. This mutant (DD750/751AA) compromises
the nucleophilic ability of the catalytic Cys residue by mutating
the Asp in its catalytic triad (Rawlings et al., 2012) and, when
expressed, it was not labeled by the DCP-Bio1 probe in an
oxidative stress-dependent manner (Figure 1G).
To assess the catalytic activity of the modified USP1, we used
ubiquitin vinyl methyl ester (UbVME) suicide substrate probe. In
brief, covalent labeling of DUBs by UbVME suggests active
protein. Importantly, the DUB activity of exogenously expressed
wild-type Usp1 was inhibited after oxidative stress (Figure 1G).
As expected, the Asp catalytic triad mutant (DD750/751AA)
was not labeled by UbVME. These results demonstrate that
the oxidation-induced inhibition of USP1 is dependent on
whether or not the active site residues are engaged in the proper
conformation for activity, strongly suggesting that DUBs are
most susceptible to oxidation when they are catalytically active.
Moreover, H2O2 treatment did not affect the association ofere treated with a final concentration of 1 mMH2O2 for the indicated amount of
M-H2DCFDA for 30 min at 37
C prior to FACS analysis. Additionally, T98G cells
, 2 mMHU for 18 hr, or MMC for 18 hr (bottom right) and trypsinized, collected,
the experiment done in triplicate.
ith the ubiquitination status of their respective substrates. U2OS cells were left
ecourse. Extracts were made in parallel to assess DUB activity by the UbVME
53 proteins.
ndogenous counterparts. 293T cells were either transfected or not for 48 hr with
ntreated or treated with 1 mMH2O2 for 30 min or with the indicated timecourse.
probed with the indicated antibodies for western blot. Additional bands that
lls were left untreated or treated with 0.3 mM H2O2 for 30 min in the absence
ith CM-H2DCFDA as in (A). In parallel analysis, samples were collected and
ent. U2OS cells were treated with 1 mM H2O2 for 30 min. Extracts were then
s in (B).
recombinant full-length USP7 is subjected to a ubiquitin cleavage assay of
cubation. DUB reaction was done in the presence or absence of 20 mM DTT.
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Usp1 with UAF1 (Figure 1H), suggesting that inhibition of USP1
by oxidative stress is not likely caused by ROS-mediated disrup-
tion of the Usp1-UAF1 complex.
Reversibility of Oxidative Stress-Induced Inactivation
of DUBs
To directly measure the duration of the ROS burst in cells treated
with H2O2, we used the cell-permeable 2
0,70-dichlorodihydro-
fluorescein diacetate (H2DCFDA) probe as a fluorescent indi-
cator for changes in ROS levels in cells. After oxidative stress,
ROS levels peaked at 30 min and were reduced to near baseline
levels by 60 min (Figure 2A). Importantly, genotoxic agents,
including hydroxyurea (HU) or mitomycin C (MMC), have been
shown to increase the cellular levels of ROS, which can affect
diverse intracellular signaling processes (Ray et al., 2012). To
assess whether other DUBs, in addition to USP1, were sus-
ceptible to inhibition by oxidative stress, and possibly through
other DNA-damaging agents, we treated U2OS cells with H2O2
at different time points and then made cell extracts and sub-
jected them to UbVME labeling. Both USP1 and another cysteine
protease DUB, USP7, were reversibly inactivated by oxidative
stress in the timecourse study (Figure 2B). USP7 plays an impor-
tant role in regulating genotoxic stress pathways and has been
shown to associate with and deubiquitinate both the tumor
suppressor protein p53 and its ubiquitin E3 ligase Mdm2 (Li
et al., 2004; Meulmeester et al., 2005). Additionally, USP7 may
also have a role in modulating histone ubiquitination levels to
enable base excision repair of oxidative lesions (Khoronenkova
et al., 2011). Despite the importance of this enzyme, the regula-
tion of USP7 activity is still not well understood. Importantly, the
DUB activity of both USP1 and USP7 inversely correlated with
the ubiquitination state of their respective substrates (Figure 2B),
suggesting that oxidative stress can regulate downstream
substrates of the DUBs. Interestingly, USP28 was not as sus-
ceptible to ROS-induced inhibition as compared to USP7 or
USP1, suggesting that other determining factors, such as the
local electrostatic environment of the catalytic cysteine or even
subcellular localization and/or scaffolding protein partners may
modulate the sensitivity of the DUB to oxidative stress. In agree-
ment with their endogenous counterparts, ectopically expressed
Flag-USP7 could be inhibited by ROS, whereas Flag-USP28modification could not be detected (data not shown). Right: MS/MS spectrum o
a sulfonic acid modification on the Cys residue and an oxidation on Met. Obse
theoretical N-terminal (b-type ion) and C-terminal (y-type ions) ion series for the o
Note that the mass error on the precursor ion and all fragment ions is better tha
spectrum.
(B) UCH-L1, but not SENP1, can be inhibited by ROS in vitro. Recombinant U
combinant SENP1CD was labeled by SUMO1-VS. Samples were preincubated
stained SDS-PAGE.
(C) AMSH cleavage of K63-linked tetraubiquitin chains is unaffected by ROS. Re
cleavage assay of K63-linked tetraubiquitin chains in the presence or absence o
absence of 20 mM DTT. Samples were then analyzed by western blot with anti-u
(D)Model depicting how reversible oxidation of USP1 couldmodulate PCNAmono
DNA damage, USP1 associated with its catalytic cofactor, UAF1, is in the catalytic
PCNA to prevent aberrant recruitment of error-prone TLS polymerases. Right:
transiently inactivated by direct oxidation of its catalytic Cys to the sulfenic acid
monoubiquitinated PCNA to engage with TLS polymerases that are responsible
damage-induced checkpoint response, the cells become more reliant on the DN
a timely manner during S phase.
Cell Rewas more refractory to this inhibition (Figure 2C). Additionally,
treatment of cells with Tempol prevents ROS-induced inactiva-
tion of DUBs (Figure 2D) and in vivo analysis of only a small
subset of DUBs suggests differential regulation of catalytic
activity by ROS (Figure 2D). We speculate that this may be due
to differences between how each DUB achieves a catalytically
competent conformation.
The Catalytic Cysteine Residue of USP7 Is the Target
of ROS-Mediated Oxidization
The timecourse study in U2OS cells suggests that USP7 activity
is fully recovered 2 hr after oxidative stress (Figure 2B). The ROS-
induced inhibition of USP7 activity in cells was shown to be
reversible by an in vitro incubation with the reducing agent
dithiothreitol (DTT), suggesting that the catalytic Cys of USP7
existed, in part, in a reversibly oxidized state inside the cell
(probably in the sulfenic acid form, Cys-SOH) (Figure 2E). To
determine whether the catalytic activity of USP7 can be modu-
lated directly by ROS in vitro, we used recombinant full-length
USP7 to show that USP7 catalytic activity, as measured by
cleavage of K48-linked tetraubiquitin chains or by the UbVME
probe, can be inhibited by preincubation with H2O2 (Figure 2F
and Figure S1C). Importantly, this in vitro ROS-induced inhibition
of USP7 is also fully reversible by DTT (Figure 2F). To verify the
active site Cys modification, we subjected USP7 to extensive
H2O2 treatment and demonstrated by tandem mass spectrom-
etry (MS/MS) that the active site Cys is modified to sulfonic
acid (Cys-SO3) (Figure 3A). Because the sulfenic acid interme-
diate is highly labile, the sulfonic acid is the only form amenable
to MS analysis. Our analysis revealed additional oxidized Cys
residues on USP7 (data not shown), which may be due to the
extensive H2O2 treatment. It is possible that under low-level
DUB oxidation, the sulfenic acid intermediate is converted to
a sulfenamide intermediate or undergoes disulfide or mixed
disulfide forms as a possible mechanism to protect the active
site Cys residue against further oxidation (Salmeen et al., 2003).
The Metalloprotease Family of DUBs Is Probably Not
Susceptible to ROS-Mediated Catalytic Inhibition
Because four of the five families of DUBs are Cys proteases, we
predict that the majority of the DUBs may achieve some level off the triply charged ion of peptide NQGAT(C)YMNSLLQTLFFTNQLR carrying
rved peptide bond cleavage is indicated in the sequence. The corresponding
bserved fragment ions is shown above and below the sequence, respectively.
n 2 ppm. Neutral loss of water from y- and b-type ions is not indicated in the
CH-L1 and USP2CD (catalytic domain) were labeled by UbVME, whereas re-
either with or without H2O2 (1 mM). Reactions were analyzed by Coomassie-
combinant USP2CD, AMSH, or AMSH plus STAM1 are subjected to ubiquitin
f H2O2 (1 mM) preincubation. The DUB reaction was done in the presence or
biquitin antibody.
ubiquitination in the presence of oxidative DNA damage. Left: in the absence of
ally active state and can readily deubiquitinate or suppress monoubiquitinated
in response to oxidative stress or oxidative DNA damage, USP1 becomes
intermediate. This renders USP1 unable to deubiquitinate PCNA, allowing for
for DNA damage tolerance and/or gap repair. In the absence of oxidative DNA
A damage tolerance pathway to ensure that the genome is fully replicated in
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susceptibility to ROS-mediated catalytic inhibition. As predicted,
using the DUB activity UbVME probe, we showed that UCH-L1,
a Cys-dependent DUB belonging to the UCH family, is also in-
hibited by ROS, like USP2, albeit to a different extent (Figure 3B).
Interestingly, a related family of cysteine proteases, SENPs,
which process the ubiquitin-like molecule SUMO, have also
been reported to undergo reversible inactivation by oxidative
stress (Bossis and Melchior, 2006; Xu et al., 2008). Under the
conditions that we use to analyze DUBs, however, the degree
of ROS sensitivity appears to be different between USP2 and
SENP1 (Figure 3B), arguing that the local environment of the
catalytic cysteine could be key in determining the threshold for
ROS sensitivity of cysteine proteases. To complete the analysis
of DUB susceptibility to oxidative stress, we tested the zinc-
dependent metalloprotease AMSH (associated molecule with
the SH3 domain of STAM) (Clague and Urbe´, 2006) for its activity
in response to oxidation. AMSH does not appear to be suscep-
tible to ROS-mediated catalytic inhibition; to show this, we as-
sayed the ability of AMSH to cleave K63-linked tetraubiquitin
chains in the presence or absence of H2O2. Although USP2
was readily inhibited by ROS, the activity of AMSH was unaf-
fected, even in the presence of STAM, the binding partner and
catalytic activator of AMSH (Figure 3C). Interestingly, treatment
of the proteins with DTT resulted in opposite effects as
compared with Cys proteases. Whereas DTT can reverse the
ROS-mediated inhibition of Cys proteases, it may slightly inhibit
the DUB activity of AMSH (Figure 3C). This is consistent with
a structural study on AMSH that showed a potential disulfide
bond between two Cys residues adjacent to the active site; the
authors reported a marginal loss of DUB activity in the Cys
mutant (Davies et al., 2011). Therefore, these studies provide
evidence that not all DUBs will react similarly to elevated levels
of ROS, and it raises the possibility that metalloproteases may
have evolved to respond to an oxidant environment in a different
manner than Cys-dependent proteases in order to maintain
some baseline level of DUB activity in cells.
In summary, we define a cellular target of oxidative stress-
induced signaling that involves ROS-mediated catalytic inhibi-
tion of Cys-dependent DUBs. This will probably have broad
implications in future studies whereby oxidative stress pathways
can regulate specific DUBs and thus their substrates involved in
developmental growth control, microbial infection, and human
diseases involving inflammation and cancer. Similar to the
PTPs, the oxidation of the catalytic Cys of DUBs is transient
and reversible, adding a layer of complexity involved in post-
translational control of DUB activity. The degree of inhibition by
ROS could be highly specific for individual DUBs, because
each could reflect differences in basal reactivity of the catalytic
site thiol or the geometry of the active site, leading to different
ranges of catalytic competency. For example, partially active
or inactive DUBs may be less susceptible to the oxidation of its
active site cysteine residue when compared to a fully active
DUB. There are many different ways DUB activity can be
regulated, one of which is substrate-induced active site confor-
mational changes, and another of which involves binding to
scaffold or adaptor proteins that can alter the activity of DUBs.
Perhaps different mechanisms to control DUB activity exist
to counteract adventitious oxidation of constitutively active1482 Cell Reports 2, 1475–1484, December 27, 2012 ª2012 The AutDUBs, because they would be more susceptible to active site
inhibition by physiological fluctuations of ROS inside the cell.
Importantly, we show that USP1 is an attractive cellular target
for reversible DUB inhibition by ROS. Transient inhibition of
USP1 activity after oxidative DNA damage will ensure a rapid
and time-dependent accumulation of monoubiquitinated
PCNA, thus allowing for DNA damage tolerance and/or gap
repair of oxidized DNA lesions during S phase (Figure 3D). This
illustrates an example of how transient inhibition of a DUB by
a burst of ROS can modulate cellular signaling pathways, under-
scoring the broad scope of the role ROS plays in modifying
enzyme functions in biology.
EXPERIMENTAL PROCEDURES
DUB Activity Assay for In Vivo Measurements
For measuring DUB activity, we used the chemically modified ubiquitin activity
probe UbVME. UbVME DUB activity assay was performed according to
Borodovsky et al. (2002) with several modifications. Cells were lysed for 1 hr
on ice with gentle tapping (250 mM Tris, 150 mM NaCl, 3 mM EDTA, and
0.5% NP40). Supernatant from cell lysis was collected after 10 min spin at
14,000 rpm at 4C. Cell extracts and 1–1.5 mg of UbVME probe (Boston Bio-
chem) were incubated at 25C for 30–90 min in DUB reaction buffer (50 mM
Tris, 50 mMNaCl, 10% glycerol, and 1 mM EDTA). Reactions were terminated
with 250 mM Tris (pH 6.8), 2% SDS, 20% glycerol, and 200 mM 2-Mercaptoe-
thanol, boiled for 10 min, and processed for western blot analysis.
Measurement of In Vivo ROS Generation
U2OS and T98G cells were treated and harvested between 60% to 80%visible
confluency. Cells were treated with hydrogen peroxide (Sigma-Aldrich) with
the concentrations and for the amount of time indicated. To measure ROS
generation in the cells, we used 5-(and-6)-chloromethyl-2,7-dichlorodihydro-
fluorescein diacetate, acetyl ester (CM-H2DCF-DA) from Invitrogen. Cells
were preincubatedwith Hoechst 33342 for 30min (final concentration 5 mg/ml),
then cells were washed, trypsinzed, and collected. Cells were then incubated
with CM-H2DCF-DA (final concentration 10 mM) and Hoechst 33342 (final
concentration 5 mg/ml) for 30 min at 37C in the dark. Next, cells were imme-
diately placed on ice and analyzed by fluorescence-activated cell sorting
(FACS). Flow cytometry analysis was performed using LSRII and analyzed
using FACS DIVA software and FlowJ 8.7 V3.1 (Verity Software House). CM-
H2DCF-DA was resuspended in 100% ethanol for a stock concentration of
10 mM (8.6 ml of 100% ethanol into the original vial with 50 mg dye). Dilution
of CM-H2DCF-DA and incubation of cells with CM-H2DCF-DA was done in
warm PBS.
Ubiquitin Cleavage and Activity Probe Assays
for Recombinant DUBs
DUBs were incubated for 15 min at room temperature in the presence or
absence of 1 mM H2O2 (preincubation), added to 300 ng tetraubiquitin chains,
and further incubated for 1 hr at 37C in 50 mM Tris (pH = 7.5), 100 mM NaCl,
1 mM EDTA, and 0.1% Tween-20 in the presence or absence of 20 mM DTT
(DUB reaction assay). Reactions were terminated by boiling in SDS-PAGE
sample buffer and then analyzed by western blotting. DUBs were used in
UbVME activity probes (SENP1-CD used in SUMO-VS activity probe) with
similar conditions as described for the ubiquitin cleavage assay. Recombinant
tetraubiquitin chains (K48 or K63 linked), UbVME, SUMO1-VS, USP7, AMSH,
STAM, SENP1-CD, and UCH-L1 were purchased from Boston Biochem (R&D
Systems); DUBs were used at a final concentration of 200 nM.
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